Reply by Authors
J Urol
.
2023 Nov;210(5):761-762.
doi: 10.1097/JU.0000000000003650.04.
Epub 2023 Nov 1.
Authors
Deepak K Pruthi
1
,
Gregor Miller
2
,
Donna P Ankerst
3
4
,
Matthias Neumair
3
,
Umberto Capitanio
5
,
Andres F Correa
6
,
Brian R Lane
7
,
Eduard Roussel
8
,
Thomas B McGregor
9
,
Ithaar H Derweesh
10
,
Mauricio Cordeiro
11
,
Phillip M Pierorazio
12
,
Carlos Calvo
13
,
Hai Bi
14
,
Sabrina L Noyes
7
,
Margaret Meagher
10
,
Alexander Kutikov
6
,
Robert G Uzzo
6
,
Hendrik Van Poppel
8
,
Alessandro Larcher
5
,
Francesco Montorsi
5
,
Michael W Kattan
15
,
Dharam Kaushik
1
,
Michael A Liss
1
Affiliations
1
University of Texas Health San Antonio, San Antonio, Texas.
2
Core Facility Statistical Consulting, Helmholtz München, Munich, Germany.
3
Department of Mathematics, Technical University of Munich, Munich, Germany.
4
Munich Data Science Institute, Munich, Germany.
5
Raffaele Department of Urology. Division of Experimental Oncology, Urological Research Institute, San Raffaele Hospital, Milan, Italy.
6
Fox Chase Cancer Center, Philadelphia, Pennsylvania.
7
Spectrum Health Cancer Center, Grand Rapids, Michigan.
8
Katholieke Universiteit Leuven, Leuven, Belgium.
9
Department of Urology, Dalhousie University, Halifax, Canada.
10
University of California San Diego, La Jolla, California.
11
Universidade de Sao Paolo, Sao Paolo, Brazil.
12
Penn Presbyterian Medical Center, University of Pennsylvania.
13
Pontificia Universidad Catolica de Chile, Santiago, Chile.
14
Department of Urology, Peking University Third Hospital, Beijing, China.
15
Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, Ohio.
PMID:
37811759
DOI:
10.1097/JU.0000000000003650.04
No abstract available
Publication types
Comment